Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
OPTimizing Treatment Focused Genetic Testing IN Cancer
- Status
- COMPLETED
- Phase
- NA
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- NA
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
- Status
- WITHDRAWN
- Phase
- PHASE2
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- Status
- RECRUITING
- Phase
- NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Understanding Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
NeoVax With Nivolumab in Patients With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
- Status
- TERMINATED
- Phase
- NA
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot
- Status
- COMPLETED
- Phase
- NA
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2